The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of retreatment with daratumumab-based regimens in anti-CD38 refractory multiple myeloma.
 
Carlyn Rose Co Tan
Employment - Janssen Research & Development (I)
Stock and Other Ownership Interests - ImmunityBio (I); Johnson & Johnson/Janssen (I); Moderna Therapeutics (I); Nektar (I); Pfizer (I)
Consulting or Advisory Role - Janssen medical Affairs
Research Funding - Janssen; Takeda
 
Colin Rueda
No Relationships to Disclose
 
Tala Shekarkhand
Honoraria - Genentech
 
Andriy Derkach
No Relationships to Disclose
 
Neha Korde
Honoraria - Cancer Network; Clinical Care Options; Intellisphere; Onc Live; PER; Remedy Health
Consulting or Advisory Role - Janssen Oncology
Research Funding - Abbvie; Amgen; Epizyme; Janssen
 
Kylee Maclachlan
No Relationships to Disclose
 
Malin Hultcrantz
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Curio Science; GlaxoSmithKline; Intellisphere; Projects in Knowledge
Research Funding - Amgen (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst)
 
Hani Hassoun
Research Funding - Janssen; Takeda
 
Sham Mailankody
Honoraria - OncLive/MJH Life Sciences; Physicans' Education Resource; Plexus
Consulting or Advisory Role - Janssen Oncology; Legend Biotech; Optum; Optum
Research Funding - Alimera Sciences (Inst); Bristol-Myers Squibb (Inst); Fate Therapeutics; Fate Therapeutics; Janssen Oncology (Inst); Juno Therapeutics (Inst); Takeda (Inst)
 
Urvi A Shah
Honoraria - MJH Life Sciences; Phillips Gilmore Oncology; RedMedEd
Consulting or Advisory Role - Bristol-Myers Squibb; i3 Health; Janssen Biotech; MashupMD; Sanofi
Research Funding - Bristol-Myers Squibb; Janssen Scientific Affairs
 
Sridevi Rajeeve
No Relationships to Disclose
 
Oscar Boutros Lahoud
Consulting or Advisory Role - MorphoSys
Travel, Accommodations, Expenses - MorphoSys
 
Gunjan L. Shah
Consulting or Advisory Role - Arcellx
Research Funding - Amgen (Inst); BeyondSpring Pharmaceuticals (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst)
 
Michael Scordo
Honoraria - i3 CME; Medscape
Consulting or Advisory Role - Angiocrine Bioscience; Kite/Gilead; McKinsey & Company; Omeros
Research Funding - Amgen (Inst); Angiocrine Bioscience; Omeros (Inst)
Travel, Accommodations, Expenses - Kite/Gilead
 
David J. Chung
Research Funding - Gentech
 
Heather Jolie Landau
Consulting or Advisory Role - Abbvie/Genentech; Nexcella; Prothena
Research Funding - Alexion Pharmaceuticals (Inst); Janssen Oncology (Inst); Protego Biopharma (Inst); Prothena (Inst)
 
Sergio Giralt
Honoraria - Amgen; Jazz Pharmaceuticals; Sanofi
Consulting or Advisory Role - Actinuum; Amgen; Bristol-Myers Squibb; Incyte; Janssen; Jazz Pharmaceuticals; Johnson & Johnson; Pfizer; Sanofi
Research Funding - Actinuum; Amgen; Celgene (Inst); Johnson & Johnson; Miltenyi Biotec (Inst); Sanofi
Travel, Accommodations, Expenses - Amgen; Celgene; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Sanofi
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Celgene; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics
 
Alexander M. Lesokhin
Honoraria - ITeos Therapeutics; Janssen; Legend Biotech; Pfizer; Sanofi; SVB Leerink; SVB Leerink; Trillium Therapeutics
Consulting or Advisory Role - Arcellx; Pfizer; Trillium Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc